Position in NRXP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$486,783
+$392,740 QoQ
Shares Held
119,018
+169.6% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 47 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRXP Over Time
Shares Held
Position Value (USD)
Derivatives in NRXP
reported options exposure · as of Jun 30, 2026CallValue
$76,074
CallShares
18,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. NRXP ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in NRXP
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,074 | 18,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $486,783 | 119,018 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $77,958 | 36,600 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $212,787 | 99,900 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $94,043 | 44,152 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $103,156 | 38,065 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $82,926 | 30,600 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $39,930 | 12,100 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $242,216 | 73,399 | Shares | Defined | 2025-11-14 | |
| 2024-03-31 | $13,066 | 27,685 | Shares | Defined | 2024-05-16 | |
| 2023-06-30 | $7,285 | 15,052 | Shares | Defined | 2023-08-14 | |
| 2021-12-31 | $256,837 | 53,732 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $262,900 | 55,000 | Call | Defined | 2022-02-15 | |
| 2021-12-31 | $312,612 | 65,400 | Put | Defined | 2022-02-15 | |
| 2021-09-30 | $404,172 | 43,600 | Put | Defined | 2021-11-16 | |
| 2021-09-30 | $701,739 | 75,700 | Call | Defined | 2021-11-16 | |
| 2021-09-30 | $714,086 | 77,032 | Shares | Defined | 2021-11-16 | |
| 2021-03-31 BRPA | — | 7,149 | Shares | Defined | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||